We, therefore, investigated TRPV2 expression with respect to melanoma invasiveness, by quantifying TRPV2 transcripts along with POU3F2(BRN2) transcription factor mRNAs, a well‐established marker of the melanoma invasive phenotype (Fane et al, 2019). This evidence concerns the gene TRPV2 and melanoma.